| mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
0.36 |
4e-10 |
| mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
0.36 |
4e-10 |
| mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
6e-08 |
| mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
7e-08 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
3e-07 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
4e-07 |
| mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
9e-07 |
| mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
1e-06 |
| mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
2e-06 |
| mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
0.33 |
3e-06 |